Daniel F. Veber - Concepedia

Author

Daniel F. Veber

Also Known As

D F Veber, D Veber, D. F. VEBER, D. F. Veber, D.F. VEBER, D.F. Veber, DANIEL F. VEBER, Daniel F Veber, Daniel F. Veber, Daniel Veber

220

Publications

17.5K

Citations

H-Index

125

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)New Frontier GlaxoSmithKline (United States)

About

Daniel F. Veber is an author at United States Military Academy specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	70	15K
2	Natural Sciences	38	61	14.3K
3	Engineering	14	14	1.2K
4	Arts	1	1	28
5	Health Sciences	1	1	136

Daniel F. Veber

106

Publications

17.2K

Citations

H-Index

Page 1

	Year	Citations
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng, Journal of Medicinal Chemistry Medicinal ChemistryOral BioavailabilityPharmaceutical ScienceDrug CandidatesBiochemistry	2002	7.8K
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists B. Evans, Kenneth E. Rittle, Mark G. Bock, Journal of Medicinal Chemistry Peptide Hormone CholecystokininMedicinal ChemistryDrug TargetBiochemistryEffective Cholecystokinin Antagonists	1988	1.4K
A potent cyclic hexapeptide analogue of somatostatin Daniel F. Veber, Roger Freidinger, Debra S. Perlow, Nature Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	1981	413
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. B. Evans, Mark G. Bock, Kenneth E. Rittle, Proceedings of the National Academy of Sciences Peptide EngineeringPeptide SciencePharmacotherapyGastrointestinal Peptide HormonePeptide Hormone Cholecystokinin	1986	327
Acetamidomethyl. A Novel Thiol Protecting Group for Cysteine Daniel F. Veber, John D. Milkowski, Sándor Varga, Journal of the American Chemical Society Pharmaceutical ScienceBiochemistryNatural SciencesCysteinedaniel VeberAltmetric Attention Score	1972	314
Bioactive Conformation of Luteinizing Hormone-Releasing Hormone: Evidence from a Conformationally Constrained Analog Roger Freidinger, Daniel F. Veber, Debra S. Perlow, Science Bioorganic ChemistryMolecular BiologyChemical BiologyPharmaceutical ChemistryBioactive Conformation	1980	313
Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260 Mark G. Bock, Robert M. DiPardo, B. Evans, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyExperimental PharmacologyTranslational PharmacologyPre-clinical Pharmacology	1989	309
HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins Paul L. Darke, Ruth F. Nutt, Stephen F. Brady, Biochemical and Biophysical Research Communications Protein FoldingPol PolyproteinsMedicineImmunologyHiv-1 Protease Specificity	1988	269
Protected lactam-bridged dipeptides for use as conformational constraints in peptides Roger Freidinger, Debra S. Perlow, Daniel F. Veber The Journal of Organic Chemistry Peptide EngineeringAltmetric Attention ScoreMolecular BiologyPeptide SciencePeptide Therapeutics	1982	222
Highly active cyclic and bicyclic somatostatin analogues of reduced ring size Daniel F. Veber, Frederick W. Holly, Ruth F. Nutt, Nature Medicinal ChemistryEngineeringHeterocyclicReduced Ring SizeDrug Discovery	1979	213

Page 1